New combo therapy tested to keep recurrent prostate cancer at bay
NCT ID NCT06654336
Summary
This study is for men whose prostate cancer has returned and spread to a few sites after initial radiation treatment. It aims to see if adding a 12-month course of hormone-blocking therapy to targeted radiation treatments works better than targeted radiation alone at keeping the cancer from progressing. Researchers will follow 162 participants for 3 years to measure cancer control, side effects, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H1T2M4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Juravinski Cancer Centre
RECRUITINGHamilton, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Ottawa Hospital Regional Cancer Centre
NOT_YET_RECRUITINGOttawa, Ontario, K1H8L6, Canada
Contact
Conditions
Explore the condition pages connected to this study.